288 related articles for article (PubMed ID: 34624433)
1. Prostate cancer dormancy and recurrence.
Cackowski FC; Heath EI
Cancer Lett; 2022 Jan; 524():103-108. PubMed ID: 34624433
[TBL] [Abstract][Full Text] [Related]
2. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
3. Regucalcin promotes dormancy of prostate cancer.
Sharma S; Pei X; Xing F; Wu SY; Wu K; Tyagi A; Zhao D; Deshpande R; Ruiz MG; Singh R; Lyu F; Watabe K
Oncogene; 2021 Feb; 40(5):1012-1026. PubMed ID: 33323968
[TBL] [Abstract][Full Text] [Related]
4. Osteoblast-Secreted Factors Mediate Dormancy of Metastatic Prostate Cancer in the Bone via Activation of the TGFβRIII-p38MAPK-pS249/T252RB Pathway.
Yu-Lee LY; Yu G; Lee YC; Lin SC; Pan J; Pan T; Yu KJ; Liu B; Creighton CJ; Rodriguez-Canales J; Villalobos PA; Wistuba II; de Nadal E; Posas F; Gallick GE; Lin SH
Cancer Res; 2018 Jun; 78(11):2911-2924. PubMed ID: 29514796
[TBL] [Abstract][Full Text] [Related]
5. Sympathetic Signaling Reactivates Quiescent Disseminated Prostate Cancer Cells in the Bone Marrow.
Decker AM; Jung Y; Cackowski FC; Yumoto K; Wang J; Taichman RS
Mol Cancer Res; 2017 Dec; 15(12):1644-1655. PubMed ID: 28814453
[TBL] [Abstract][Full Text] [Related]
6. Mer Tyrosine Kinase Regulates Disseminated Prostate Cancer Cellular Dormancy.
Cackowski FC; Eber MR; Rhee J; Decker AM; Yumoto K; Berry JE; Lee E; Shiozawa Y; Jung Y; Aguirre-Ghiso JA; Taichman RS
J Cell Biochem; 2017 Apr; 118(4):891-902. PubMed ID: 27753136
[TBL] [Abstract][Full Text] [Related]
7. Tumor removal limits prostate cancer cell dissemination in bone and osteoblasts induce cancer cell dormancy through focal adhesion kinase.
Liu R; Su S; Xing J; Liu K; Zhao Y; Stangis M; Jacho DP; Yildirim-Ayan ED; Gatto-Weis CM; Chen B; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):264. PubMed ID: 37821954
[TBL] [Abstract][Full Text] [Related]
8. Osteoblastic protein kinase D1 contributes to the prostate cancer cells dormancy via GAS6-circadian clock signaling.
Li G; Fan M; Zheng Z; Zhang Y; Zhang Z; Huang Z; Luo W; Zhao W; Lai X; Chen H; Zeng F; Deng F
Biochim Biophys Acta Mol Cell Res; 2022 Sep; 1869(9):119296. PubMed ID: 35595103
[TBL] [Abstract][Full Text] [Related]
9. Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.
Yumoto K; Eber MR; Wang J; Cackowski FC; Decker AM; Lee E; Nobre AR; Aguirre-Ghiso JA; Jung Y; Taichman RS
Sci Rep; 2016 Nov; 6():36520. PubMed ID: 27819283
[TBL] [Abstract][Full Text] [Related]
10. GAS6 receptor status is associated with dormancy and bone metastatic tumor formation.
Taichman RS; Patel LR; Bedenis R; Wang J; Weidner S; Schumann T; Yumoto K; Berry JE; Shiozawa Y; Pienta KJ
PLoS One; 2013; 8(4):e61873. PubMed ID: 23637920
[TBL] [Abstract][Full Text] [Related]
11. Wnt5a induces and maintains prostate cancer cells dormancy in bone.
Ren D; Dai Y; Yang Q; Zhang X; Guo W; Ye L; Huang S; Chen X; Lai Y; Du H; Lin C; Peng X; Song L
J Exp Med; 2019 Feb; 216(2):428-449. PubMed ID: 30593464
[TBL] [Abstract][Full Text] [Related]
12. Bone secreted factors induce cellular quiescence in prostate cancer cells.
Yu-Lee LY; Lee YC; Pan J; Lin SC; Pan T; Yu G; Hawke DH; Pan BF; Lin SH
Sci Rep; 2019 Dec; 9(1):18635. PubMed ID: 31819067
[TBL] [Abstract][Full Text] [Related]
13. Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.
Kobayashi A; Okuda H; Xing F; Pandey PR; Watabe M; Hirota S; Pai SK; Liu W; Fukuda K; Chambers C; Wilber A; Watabe K
J Exp Med; 2011 Dec; 208(13):2641-55. PubMed ID: 22124112
[TBL] [Abstract][Full Text] [Related]
14. Abscisic acid regulates dormancy of prostate cancer disseminated tumor cells in the bone marrow.
Jung Y; Cackowski FC; Yumoto K; Decker AM; Wang Y; Hotchkin M; Lee E; Buttitta L; Taichman RS
Neoplasia; 2021 Jan; 23(1):102-111. PubMed ID: 33296752
[TBL] [Abstract][Full Text] [Related]
15. The biology and clinical implications of prostate cancer dormancy and metastasis.
Morrissey C; Vessella RL; Lange PH; Lam HM
J Mol Med (Berl); 2016 Mar; 94(3):259-65. PubMed ID: 26489605
[TBL] [Abstract][Full Text] [Related]
16. Tumor Dormancy: Implications for Invasion and Metastasis.
Gomatou G; Syrigos N; Vathiotis IA; Kotteas EA
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064392
[TBL] [Abstract][Full Text] [Related]
17. Cellular Adhesion Promotes Prostate Cancer Cells Escape from Dormancy.
Ruppender N; Larson S; Lakely B; Kollath L; Brown L; Coleman I; Coleman R; Nguyen H; Nelson PS; Corey E; Snyder LA; Vessella RL; Morrissey C; Lam HM
PLoS One; 2015; 10(6):e0130565. PubMed ID: 26090669
[TBL] [Abstract][Full Text] [Related]
18. Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth.
Metz EP; Wuebben EL; Wilder PJ; Cox JL; Datta K; Coulter D; Rizzino A
BMC Cancer; 2020 Oct; 20(1):941. PubMed ID: 32998722
[TBL] [Abstract][Full Text] [Related]
19. Dormancy in cancer.
Endo H; Inoue M
Cancer Sci; 2019 Feb; 110(2):474-480. PubMed ID: 30575231
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Metastatic Tumor Dormancy and Emerging Opportunities for Therapeutic Intervention.
Tamamouna V; Pavlou E; Neophytou CM; Papageorgis P; Costeas P
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]